| Serial Number | 88667306 |
| Word Mark | PARVULET |
| Filing Date | Thursday, October 24, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 16, 2021 |
| Registration Number | 6269377 |
| Registration Date | Tuesday, February 16, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 1, 2020 |
| Goods and Services | Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials for others |
| Goods and Services | Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, fever management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, inflammation, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, disbiosys, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes, namely, for the treatment of illnesses characterized by lack of such peptides and analogues thereof; vitamins; biologics being biopharmaceuticals and biologically active substances for the treatment of exocrine pancreatic insufficiency, cystic fibrosis; pharmaceutical and nutraceuticals preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral powder, oral liquids, oral suspensions, oral gels, and oral emulsions for the immediate or controlled, extended, delayed, pulsatile, local release release of a wide variety of therapeutic agents within a certain time after ingestion; oral powder for reconstitution, namely for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents within a certain time after ingestion; medical gel; medicated candy; medicated chewing gum; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds and nutraceuticals; drug delivery systems comprising polymer-based oral tablets, oral powder for immediate or controlled, extended, delayed, pulsatile, local release of a wide variety of therapeutic agents; drug delivery agents for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, powder, emulsions; drug delivery powder for reconstitution in water before administration |
| Translation of Words in Mark | The wording "PARVULET" has no meaning in a foreign language. |
| Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers in the nature of blister packs and sachets for various pharmaceuticals, drugs, medicines, compounds and substances sold without medication; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems, namely, drug delivery patches sold without medication, implantable drug delivery ports, intravenous bags sold empty for intravenous therapy |
| Goods and Services | Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, fever management, inflammation, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, disbiosys diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research, design and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates and biologics; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines with improved compliance and acceptability by the patients; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like, gelling and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing solid dosage forms such as pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs and biologics; biochemical and molecular biological analyses of pharmaceuticals and nutraceuticals preparations to ensure efficacy and safety; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides or other biologics analogues for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs; preparation of materials for promotional documents and campaigns |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 30, 2019 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 30, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 30, 2019 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 30, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADARE PHARMACEUTICALS, INC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19111 |
| Party Name | ADARE PHARMACEUTICALS, INC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | ADARE PHARMACEUTICALS, INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Event Date | Event Description |
| Monday, October 28, 2019 | NEW APPLICATION ENTERED |
| Wednesday, October 30, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 3, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, January 30, 2020 | ASSIGNED TO EXAMINER |
| Monday, February 3, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, February 3, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 22, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 2, 2020 | ASSIGNED TO LIE |
| Thursday, July 23, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, July 23, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, July 2, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 2, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 23, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 16, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 16, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, October 17, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 19, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, October 26, 2020 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, October 23, 2020 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, November 11, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 1, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 1, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 16, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, February 20, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, February 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, February 20, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |